July 16, 2020
#ShutdownStem and Black Lives Matter: Call for Diversity in Science, Medicine & Academia

Click here to view the event recording.
Click here to view the event program.

On June 10, 2020, thousands of researchers around the world paused their work to support the ongoing Black Lives Matter movement and efforts against racism in the scientific community and society at large. Responding to calls from organizations such as Strike For Black Lives, #ShutDownSTEM and #ShutDownAcademia, individuals in university laboratories, scientific societies, technical journals and many others engaged in a week of communication on Twitter, participated in local protests and studied the history of systemic racism in virtual education events, ceased to announce new submissions for publications, and marched on their scientific institutions.

These events were meant to call attention to the dramatic disparity in representation, retention and recruitment of black scientists and doctors in academia, where only 9% of STEM workers in the US are black compared to 69% who are white, according to the PEW Center. Black professors made up only about 2% of full-time professors in 2017. These efforts followed the publication of the First Annual Report on Measuring Diversity in the Biotech Industry by the Biotechnology Industry Organization in January 2020.


1:00 PM – 1:05 PM

Welcome and Overview of the Meeting

  • Nancy J Kelley, President & CEO, Nancy J Kelley + Associates, Steering Committee, NYC Builds Bio+
  • Tim Sanders, Senior Investment Officer, Ventas
  • 1:05 PM – 1:50 PM Panel Presentation
    Anthony Johnson, President & CEO, Kodikaz, Founding Partner, Buffalo Biosciences
  • Nancy J Kelley, President & CEO, Nancy J Kelley + Associates, Steering Committee, NYC Builds Bio+


  • Ann-Gel Palermo, DrPH, MPH, Associate Dean for Diversity & Inclusion, Chief Program Officer/Co-
    Founder at Diversity Innovation Hub, Icahn School of Medicine at Mount Sinai
  • Asha S. Collins, PhD, Head of US, Country Clinical Operations, Genentech and Aspen Institute
    Health Innovators Fellow
  • Emmanuel F. Fombu, MD, MBA, Venture Partner, FundRx, VP Locust Walk Partners, Author: The
    Future of Healthcare, Prior Medical Director Novartis, Bayer, Johnson & Johnson
  • Teresia Bost, JD, General Counsel, Quartet Health, Prior Senior Corporate Counsel, Celgene
  • Mark Hicks, Associate Scientist: Cell Biology, Lab Manager & HSE (Health, Safety, Environment)
    Representative, Loxo Oncology at Eli Lilly Corp

1:50 PM – 2:00 PM Q&A With Audience

2:00 PM – 2:30 PM Networking